These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 19402057)
1. Tissue biomarkers in renal cell carcinoma: issues and solutions. Di Napoli A; Signoretti S Cancer; 2009 May; 115(10 Suppl):2290-7. PubMed ID: 19402057 [TBL] [Abstract][Full Text] [Related]
2. Identification and validation of novel prognostic markers in Renal Cell Carcinoma. Rabjerg M Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890 [TBL] [Abstract][Full Text] [Related]
3. [Diagnostic and prognostic markers of renal cell carcinoma]. Spadaccino F; Netti GS; Rocchetti MT; Castellano G; Stallone G; Ranieri E G Ital Nefrol; 2020 Apr; 37(2):. PubMed ID: 32281759 [TBL] [Abstract][Full Text] [Related]
4. Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis. Perumal K; Huin WK; Yap NY; Ong TA; Gobe GC; Rajandram R Med Hypotheses; 2019 Aug; 129():109239. PubMed ID: 31371068 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis. Osunkoya AO; Yin-Goen Q; Phan JH; Moffitt RA; Stokes TH; Wang MD; Young AN Hum Pathol; 2009 Dec; 40(12):1671-8. PubMed ID: 19695674 [TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy. Stillebroer AB; Mulders PF; Boerman OC; Oyen WJ; Oosterwijk E Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812 [TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase IX immunohistochemistry has potential to predict renal cell carcinoma outcomes: A systematic review and meta-analyses. Samberkar S; Rajandram R; Mun KS; Samberkar P; Danaee M; Zulkafli IS Malays J Pathol; 2019 Dec; 41(3):233-242. PubMed ID: 31901907 [TBL] [Abstract][Full Text] [Related]
8. [Metabonome in Early Diagnosis of Renal Cell Carcinoma]. Wang Z; Zhang YS Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):709-713. PubMed ID: 31699205 [TBL] [Abstract][Full Text] [Related]
10. Biomarkers of Renal Tumors: the Current State and Clinical Perspectives. Golovastova MO; Korolev DO; Tsoy LV; Varshavsky VA; Xu WH; Vinarov AZ; Zernii EY; Philippov PP; Zamyatnin AA Curr Urol Rep; 2017 Jan; 18(1):3. PubMed ID: 28110463 [TBL] [Abstract][Full Text] [Related]
11. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma. Yao M; Tabuchi H; Nagashima Y; Baba M; Nakaigawa N; Ishiguro H; Hamada K; Inayama Y; Kishida T; Hattori K; Yamada-Okabe H; Kubota Y J Pathol; 2005 Feb; 205(3):377-87. PubMed ID: 15682440 [TBL] [Abstract][Full Text] [Related]
12. Urinary microRNAs: Looking for a New Tool in Diagnosis, Prognosis, and Monitoring of Renal Cancer. Oto J; Plana E; Sánchez-González JV; García-Olaverri J; Fernández-Pardo Á; España F; Martínez-Sarmiento M; Vera-Donoso CD; Navarro S; Medina P Curr Urol Rep; 2020 Mar; 21(2):11. PubMed ID: 32166474 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA GIHCG is a potential diagnostic and prognostic biomarker and therapeutic target for renal cell carcinoma. He ZH; Qin XH; Zhang XL; Yi JW; Han JY Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):46-54. PubMed ID: 29364470 [TBL] [Abstract][Full Text] [Related]
15. Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma. Sato T; Kawasaki Y; Maekawa M; Takasaki S; Saigusa D; Ota H; Shimada S; Yamashita S; Mitsuzuka K; Yamaguchi H; Ito A; Kinoshita K; Koshiba S; Mano N; Arai Y Int J Cancer; 2019 Jul; 145(2):484-493. PubMed ID: 30628065 [TBL] [Abstract][Full Text] [Related]
16. Current and Future Biomarkers in the Management of Renal Cell Carcinoma. Reese S; Calderon L; Khaleel S; Hakimi AA Urol Clin North Am; 2023 Feb; 50(1):151-159. PubMed ID: 36424079 [TBL] [Abstract][Full Text] [Related]
17. PAX-2 in the diagnosis of primary renal tumors: immunohistochemical comparison with renal cell carcinoma marker antigen and kidney-specific cadherin. Ozcan A; Zhai J; Hamilton C; Shen SS; Ro JY; Krishnan B; Truong LD Am J Clin Pathol; 2009 Mar; 131(3):393-404. PubMed ID: 19228645 [TBL] [Abstract][Full Text] [Related]
18. Molecular detection of von Hippel-Lindau gene mutations in urine and lymph node samples in patients with renal cell carcinoma: potential biomarkers for early diagnosis and postoperative metastatic status. Ashida S; Furihata M; Tanimura M; Sugita O; Yamashita M; Miura T; Moriyama M; Shuin T J Urol; 2003 Jun; 169(6):2089-93. PubMed ID: 12771725 [TBL] [Abstract][Full Text] [Related]
19. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Liao SY; Aurelio ON; Jan K; Zavada J; Stanbridge EJ Cancer Res; 1997 Jul; 57(14):2827-31. PubMed ID: 9230182 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature. Zhao Z; Liao G; Li Y; Zhou S; Zou H; Fernando S PLoS One; 2014; 9(11):e114096. PubMed ID: 25426861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]